News Sentiment

MBIO sentiment intelligence

Mustang Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 44 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.63 Week of 17 Jul 2026
Weighted tone 44/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 38

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-10.7% over one week, -3.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Mustang Bio stock trades lower as cash runway and trial update shape outlook

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -10.7% Price reacting lower
Trend fit Trend inactive -3.4% over four weeks
Fair value -97.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 26
Negative 17

Relevance

Why the article matched

Direct first
Direct company coverage 38
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
TradingKey 9
Market source 6
dars.gov.et 4
Quartr 3
Simply Wall Street 2
AD HOC NEWS 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Earnings 21
Market update 21
Balance sheet 3
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-47 of 47
TradingKey Direct company coverage

Mustang Bio Inc MBIO

This page provides an overview of Mustang Bio Inc. (MBIO) stock, including its current price, market capitalization, and performance. It indicates a closing price of 0.660 USD, a decrease of 5.17%, and shows after-hours trading at 0.000 USD. The page offers various financial anal

Tone
Negative 30/100
Event
Market update
Published
12 May 2026 02:10
Source
TradingKey
Stock Titan Direct company coverage

Mustang Bio (NASDAQ: MBIO) CEO reports 19-share tax withholding event

Mustang Bio's President, CEO, and Interim CFO, Manuel Litchman, reported a routine tax-withholding transaction on April 24, 2026. He relinquished 19 shares of common stock at $0.75 per share to cover tax liability related to the vesting of restricted stock units. This was not an

Tone
Neutral 50/100
Event
Market update
Published
27 Apr 2026 19:38
Source
Stock Titan
TradingView Direct company coverage

Mustang Bio Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Mustang Bio (MBIO) received a notice from Nasdaq on April 15, 2026, indicating non-compliance with the minimum $1.00 bid price rule for 30 consecutive business days. The company has until October 12, 2026, to regain compliance by achieving a closing bid price of at least $1.00 fo

Tone
Negative 14/100
Event
Market update
Published
18 Apr 2026 01:09
Source
TradingView
Stock Titan Direct company coverage

Nasdaq warns Mustang Bio (MBIO) on sub-$1 share price and listing risk

Mustang Bio Inc. (MBIO) has received a notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement, as its stock traded below this level for 30 consecutive business days. The company now has a 180-day grace period, until October 12, 2026, to regain compliance b

Tone
Negative 29/100
Event
Market update
Published
17 Apr 2026 19:39
Source
Stock Titan
ADVFN Direct company coverage

Form S-1 - General form for registration of securities under the Securities Act of 1933

Mustang Bio, Inc. has filed a Form S-1 registration statement with the SEC to register the resale of up to 2,743,530 shares of its Common Stock by selling stockholders. These shares are issuable upon the exercise of warrants. The company will not receive any proceeds from these s

Tone
Neutral 50/100
Event
Market update
Published
17 Apr 2026 07:40
Source
ADVFN
Kavout Direct company coverage

Is Mustang Bio (MBIO) a Hidden Gem in the Microbiome Revolution, or a Risky Bet

Mustang Bio (MBIO) is a clinical-stage biopharmaceutical company trading at a micro-cap valuation, focusing on cell and gene therapies for cancers and rare genetic diseases. While the broader biotech market is enthusiastic about microbiome-targeted interventions, MBIO's current p

Tone
Negative 34/100
Event
Market update
Published
12 Apr 2026 05:10
Source
Kavout
Zacks Investment Research Direct company coverage

Should I buy Mustang Bio (MBIO)

Tone
Positive 66/100
Event
Market update
Published
31 Aug 2017 02:42
Source
Zacks Investment Research